publication venue for
- Qualitative comparison of perioperative anticoagulation management guidelines across US institutions.. 257. 2025
- Comparative analysis of perioperative management of antiplatelet agent guidelines across US institutions.. 255. 2025
- Pulmonary embolism versus pulmonary vasculitis in Hughes-Stovin syndrome: Characteristic computed tomography pulmonary angiographic findings and diagnostic and therapeutic implications. HSS International Study Group.. 239. 2024
- Interest in the new thromboelastometry device, Clot Pro®, for predicting thrombocytopenia and hypofibrinogenemia during lung transplantation.. 233. 2023
- Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies.. 225. 2023
- Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial.. 211. 2022
- Transition of care for pediatric and adult patients with venous thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN).. 200. 2021
- Right ventricular stroke distance predicts death and clinical deterioration in patients with pulmonary embolism.. 195. 2020
- D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19. 196:318-321. 2020
- Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists.. 185. 2019
- The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.. 175. 2019
- Dabigatran reduces endothelial permeability through inhibition of thrombin-induced cytoskeleton reorganization. 2018
- Transition of care for patients with venous thromboembolism: Rationale, design and implementation of a quality intervention project conducted at American Thrombosis and Hemostasis Network (ATHN) affiliated sites.. 163. 2018
- Variants in chondroitin sulfate metabolism genes in thrombotic storm.. 161. 2017
- A novel 2-stage approach that detects complement activation in patients with antiphospholipid antibody syndrome.. 156. 2017
- Inverted erythrocyte membranes demonstrate β2GPI-antiphospholipid antibody interactions and membrane crosslinking.. 146. 2016
- Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.. 144. 2016
- OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin.. 140 Suppl 1. 2016
- PO-43 - Differential coagulation factor expression in neuroendocrine prostate cancer (PC), metastatic castrate-resistant PC, and localized prostatic adenocarcinoma.. 140 Suppl 1. 2016
- Elevated levels of full-length and thrombin-cleaved osteopontin during acute dengue virus infection are associated with coagulation abnormalities.. 134. 2014
- Controlled reperfusion with intravenous bivalirudin and intracoronary abciximab combination therapy in the porcine myocardial infarction model.. 130. 2011
- Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease.. 117. 2006
- Effect of mild hypothermia on the thrombolytic efficacy of 120 kHz ultrasound enhanced thrombolysis in an in-vitro human clot model.. 117. 2005
- Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies.. 106. 2002
- Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.. 105. 2002
- Prothrombin activation fragment (F1.2) is increased in pregnant patients with antiphospholipid antibodies.. 85. 1997
- Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies.. 84. 1996
- Reduced thrombogenicity of type VI collagen as compared to type I collagen.. 79. 1995
- Membrane fluidity and thromboxane synthesis in platelets from patients with severe atherosclerosis.. 44. 1986
- Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina.. 28. 1982
- Platelet FcIgG receptor: increased expression in female platelets.. 21. 1981
- The interaction of platelets and concanavalin A.. 7. 1975
- The effect of race on composite thrombotic events in patients with COVID-19.. 199. 2020
- Identification of thrombosis-related conformational binding epitopes on domain I of β2-glycoprotein I. 2024
- Comment on: "The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome". 2017
- Defective annexin A5 crystallization: a mechanism for pregnancy losses in the antiphospholipid syndrome. 2005
- Treatment of congenital bleeding disorders: future trends in management.. 124 Suppl 2. 2009
- The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis. 2016
- Antibody-mediated interference with annexins in the antiphospholipid syndrome. 2004